Proscar
Company: Merck
Approval Status: Approved April 1998
Treatment for: reducing the need for prostate surgery
Areas: Endocrinology; Nephrology/Urology
General Information
Other Useful Resources
Proscar has been approved for the reduction of the need for prostate surgery and the risk of developing acute urinary retention, a complication of BPH.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
